Related references
Note: Only part of the references are listed.A potent HDAC inhibitor blocks Toxoplasma gondii tachyzoite growth and profoundly disrupts parasite gene expression
Thomas Mouveaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
Behavioral Manipulation by Toxoplasma gondi: Does Brain Residence Matter?
Samira Abdulai-Saiku et al.
TRENDS IN PARASITOLOGY (2021)
HDAC inhibitors Tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics
Carlla Assis Araujo-Silva et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2021)
New life for an old drug: In vitro and in vivo effects of the anthelmintic drug niclosamide against Toxoplasma gondii RH strain
Ji Li Zhang et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2019)
Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil
Leticia Azevedo Silva et al.
EXPERIMENTAL PARASITOLOGY (2019)
A Tiny Change Makes a Big Difference in the Anti-Parasitic Activities of an HDAC Inhibitor
Corinne Loeuillet et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Diversity of Toxoplasma gondii strains at the global level and its determinants
L. Galal et al.
FOOD AND WATERBORNE PARASITOLOGY (2019)
Treatment of toxoplasmosis: Current options and future perspectives
Neda Konstantinovic et al.
FOOD AND WATERBORNE PARASITOLOGY (2019)
Synthesis of aminophenylhydroxamate and aminobenzylhydroxamate derivatives and in vitro screening for antiparasitic and histone deacetylase inhibitory activity
C. Loeuillet et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice
Ildiko Rita Dunay et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Drug Resistance in Toxoplasma gondii
Mahbobeh Montazeri et al.
FRONTIERS IN MICROBIOLOGY (2018)
Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil
Leticia Azevedo Silva et al.
PLOS ONE (2017)
Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review
Ruben R. Ben-Harari et al.
DRUGS IN R&D (2017)
Antimalarial Drug Resistance: A Threat to Malaria Elimination
Didier Menard et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis
Mark P. Connolly et al.
PATHOGENS AND GLOBAL HEALTH (2017)
A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006–2016)
Mahbobeh Montazeri et al.
Frontiers in Microbiology (2017)
Bioluminescence Method for In Vitro Screening of Plasmodium Transmission-Blocking Compounds
Raquel Azevedo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity
Madalyn M. McFarland et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Pathogenicity and phenotypic sulfadiazine resistance of Toxoplasma gondii isolates obtained from livestock in northeastern Brazil
Claudio B. S. Oliveira et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2016)
Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis
A. L. Sutterland et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Mechanisms of Host Behavioral Change in Toxoplasma gondii Rodent Association
Ajai Vyas
PLOS PATHOGENS (2015)
Ocular toxoplasmosis II: clinical features, pathology and management
Nicholas J. Butler et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)
Genetic Characterization of Toxoplasma gondii Revealed Highly Diverse Genotypes for Isolates from Newborns with Congenital Toxoplasmosis in Southeastern Brazil
Ana Carolina Aguiar Vasconcelos Carneiro et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Development of High-Throughput Methods to Quantify Cysts of Toxoplasma gondii
D. Aldebert et al.
CYTOMETRY PART A (2011)
Human impact on genetic diversity of Toxoplasma gondii: Example of the anthropized environment from French Guiana
A. Mercier et al.
INFECTION GENETICS AND EVOLUTION (2011)
Activity of the Histone Deacetylase Inhibitor FR235222 on Toxoplasma gondii: Inhibition of Stage Conversion of the Parasite Cyst Form and Study of New Derivative Compounds
Daniele Maubon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Chromatin modifications: implications in the regulation of gene expression in Toxoplasma gondii
Alexandre Bougdour et al.
CELLULAR MICROBIOLOGY (2010)
Visualisation and Quantitative Analysis of the Rodent Malaria Liver Stage by Real Time Imaging
Ivo H. J. Ploemen et al.
PLOS ONE (2009)
Severe Acquired Toxoplasmosis Caused by Wild Cycle of Toxoplasma gondii, French Guiana
Bernard Carme et al.
EMERGING INFECTIOUS DISEASES (2009)
Case report:: A typical Toxoplasma gondii strain from a free-living jaguar (Panthera onca) in French Guiana
M. Demar et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2008)
Toxoplasma gondii infection in humans and animals in the United States
J. P. Dubey et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2008)
Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro
Jeannine S. Strobl et al.
JOURNAL OF PARASITOLOGY (2007)
Innate refractoriness of the Lewis rat to toxoplasmosis is a dominant trait that is intrinsic to bone marrow-derived cells
W Sergent et al.
INFECTION AND IMMUNITY (2005)
Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana
B Carme et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Evaluation of a cyclic GMP-dependent protein kinase inhibitor in treatment of murine toxoplasmosis: Gamma interferon is required for efficacy
B Nare et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Long-term optional ingestion of corn oil induces excessive caloric intake and obesity in mice
M Takeda et al.
NUTRITION (2001)
Radiolabeling, stability, and body distribution in rats, of low molecular weight polylactide homopolymer and polylactide-polyethyleneglycol copolymer
JF Bridges et al.
BIOMATERIALS (2000)
Share Paper
